The Program in Virology and Gene Therapy
Dear Prospective Student,
The Program in Virology and Gene Therapy (VGT) welcomes you. As a member of this program, you will have the opportunity to do research in molecular virology, as well as applied research in gene therapy using both modified viral and non-viral vectors. Faculty members are associated with The University of Texas (UT) MD Anderson Cancer Center (in Houston, Bastrop, and Smithville), The UT Health Science Center at Houston, The UT School of Public Health (in both Houston and Brownsville), and also the Texas A&M University Institute of Biosciences and Technology. Research is currently underway in the molecular genetics of arteriosclerosis, vascular targeting using phage display, controlling the expression of oncogenes by delivering proteins using viral and non-viral vectors, vaccine development, as well as conducting basic and translational research in both human immunodeficiency virus (HIV) and human papillomavirus (HPV), just to name a few.
Virology and Gene Therapy is a truly unique inter-institutional, multi-disciplinary program encompassing fundamental basic research, translational research and clinical research. Courses offered in the program combined with the tutorial research in the laboratories of various program faculty offers the best possible training to students interested in the biology and pathophysiology of viruses and/or novel approaches to use viral and non-viral agents to repair/treat genetic and immune abnormalities.
The VGT Students
Rat-1 cells transduced with a lentivirus carrying a gene encoding the red fluorescent protein (courtesy of Dr. R. B. Arlinghaus).
Non-Hodgkin's lymphoma lesions stained with the PAB-419 antibody that detects SV40 large T antigen as a specific tumor antigen of viral origin (courtesy of Dr. F. Samaniego).